| The broad spectrum of human natural killer cell diversity AG Freud, BL Mundy-Bosse, J Yu, MA Caligiuri Immunity 47 (5), 820-833, 2017 | 598 | 2017 |
| Ibrutinib treatment improves T cell number and function in CLL patients M Long, K Beckwith, P Do, BL Mundy, A Gordon, AM Lehman, ... The Journal of clinical investigation 127 (8), 3052-3064, 2017 | 355 | 2017 |
| Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice BL Mundy-Bosse, GB Lesinski, AC Jaime-Ramirez, K Benninger, M Khan, ... Cancer research 71 (15), 5101-5110, 2011 | 231 | 2011 |
| Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants BL Andersen, LM Thornton, CL Shapiro, WB Farrar, BL Mundy, HC Yang, ... Clinical Cancer Research 16 (12), 3270-3278, 2010 | 209 | 2010 |
| Nitric oxide production by myeloid-derived suppressor cells plays a role in impairing Fc receptor–mediated natural killer cell function A Stiff, P Trikha, B Mundy-Bosse, E McMichael, TA Mace, B Benner, ... Clinical Cancer Research 24 (8), 1891-1904, 2018 | 202 | 2018 |
| A progenitor cell expressing transcription factor RORγt generates all human innate lymphoid cell subsets SD Scoville, BL Mundy-Bosse, MH Zhang, L Chen, X Zhang, KA Keller, ... Immunity 44 (5), 1140-1150, 2016 | 198 | 2016 |
| Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia IK Park, B Mundy-Bosse, SP Whitman, X Zhang, SL Warner, DJ Bearss, ... Leukemia 29 (12), 2382-2389, 2015 | 162 | 2015 |
| Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy BL Mundy-Bosse, GS Young, T Bauer, E Binkley, M Bloomston, MA Bill, ... Cancer Immunology, Immunotherapy 60, 1269-1279, 2011 | 149 | 2011 |
| Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments AK Sasser, BL Mundy, KM Smith, AW Studebaker, AE Axel, AM Haidet, ... Cancer letters 254 (2), 255-264, 2007 | 148 | 2007 |
| Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease J Markowitz, TR Brooks, MC Duggan, BK Paul, X Pan, L Wei, Z Abrams, ... Cancer Immunology, Immunotherapy 64, 149-159, 2015 | 127 | 2015 |
| IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production AC Jaime-Ramirez, BL Mundy-Bosse, SV Kondadasula, NB Jones, ... The Journal of Immunology 186 (6), 3401-3409, 2011 | 125 | 2011 |
| NKp80 defines a critical step during human natural killer cell development AG Freud, KA Keller, SD Scoville, BL Mundy-Bosse, S Cheng, Y Youssef, ... Cell reports 16 (2), 379-391, 2016 | 119 | 2016 |
| Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients BL Mundy-Bosse, LM Thornton, HC Yang, BL Andersen, WE Carson Cellular immunology 270 (1), 80-87, 2011 | 119 | 2011 |
| CD56 expression marks human group 2 innate lymphoid cell divergence from a shared NK cell and group 3 innate lymphoid cell developmental pathway L Chen, Y Youssef, C Robinson, GF Ernst, MY Carson, KA Young, ... Immunity 49 (3), 464-476. e4, 2018 | 108 | 2018 |
| The IL-15–AKT–XBP1s signaling pathway contributes to effector functions and survival in human NK cells Y Wang, Y Zhang, P Yi, W Dong, AP Nalin, J Zhang, Z Zhu, L Chen, ... Nature immunology 20 (1), 10-17, 2019 | 91 | 2019 |
| Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function SD Scoville, AP Nalin, L Chen, L Chen, MH Zhang, K McConnell, ... Blood, The Journal of the American Society of Hematology 132 (17), 1792-1804, 2018 | 76 | 2018 |
| Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells R Trotta, L Chen, S Costinean, S Josyula, BL Mundy-Bosse, D Ciarlariello, ... Blood, The Journal of the American Society of Hematology 121 (16), 3126-3134, 2013 | 76 | 2013 |
| Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis KD Guenterberg, VP Grignol, ET Raig, JM Zimmerer, AN Chan, ... Molecular cancer therapeutics 9 (2), 510-520, 2010 | 70 | 2010 |
| MicroRNA-29b mediates altered innate immune development in acute leukemia BL Mundy-Bosse, SD Scoville, L Chen, K McConnell, HC Mao, EH Ahmed, ... The Journal of clinical investigation 126 (12), 4404-4416, 2016 | 62 | 2016 |
| SMAD4 promotes TGF-β–independent NK cell homeostasis and maturation and antitumor immunity Y Wang, J Chu, P Yi, W Dong, J Saultz, Y Wang, H Wang, S Scoville, ... The Journal of clinical investigation 128 (11), 5123-5136, 2019 | 61 | 2019 |
